EUCTR2015-005234-21-NLActive, not recruitingPhase 1
A Phase 3b Multicenter, Single-Arm, Open-Label Safety Study of LY2951742 (galcanezumab) in Patients with Episodic or Chronic Cluster Headache
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Eli Lilly and Company
- Enrollment
- 324
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Participants who participated in and completed either Study CGAL or Study CGAM.
- •Investigator judges the participant as reliable to follow all study procedures, keep all study visits, and be compliant with study requirements.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 304
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 20
Exclusion Criteria
- •Current enrollment in or discontinuation within the last 30 days from, a clinical trial involving any investigational drug or device (with the exception of Study CGAL or Study CGAM).
- •Current use or any prior exposure to any calcitonin-gene-related peptide (CGRP) antibody, any antibody to the CGRP receptor, or antibody to nerve growth factor (NGF) (with the exception of Study CGAL or Study CGAM).
- •A history of migraine variants that could implicate or could be confused with ischemia.
- •Known hypersensitivity to multiple drugs, monoclonal antibodies or other therapeutic proteins.
- •A history or presence of other medical illness that indicates a medical problem that would preclude study participation.
- •Evidence of significant active or unstable psychiatric disease, in the opinion of the investigator.
- •Women who are pregnant or nursing.
Investigators
Similar Trials
Active, not recruiting
Phase 1
A Study in Patients With Cluster HeadacheEpisodic Cluster Headache, Chronic Cluster HeadacheMedDRA version: 20.0Level: PTClassification code 10059133Term: Cluster headacheSystem Organ Class: 10029205 - Nervous system disordersEUCTR2015-005234-21-DEEli Lilly and Company324
Active, not recruiting
Phase 1
A Study in Patients With Cluster HeadacheEpisodic Cluster Headache, Chronic Cluster HeadacheMedDRA version: 20.0Level: PTClassification code 10059133Term: Cluster headacheSystem Organ Class: 10029205 - Nervous system disordersEUCTR2015-005234-21-DKEli Lilly and Company324
Active, not recruiting
Phase 1
A Study in Patients With Cluster HeadacheEpisodic Cluster Headache, Chronic Cluster HeadacheMedDRA version: 19.0Level: PTClassification code 10059133Term: Cluster headacheSystem Organ Class: 10029205 - Nervous system disordersEUCTR2015-005234-21-ESilly S.A.165
Active, not recruiting
Phase 1
A Study in Patients With Cluster HeadacheEpisodic Cluster Headache, Chronic Cluster HeadacheMedDRA version: 20.0Level: PTClassification code 10059133Term: Cluster headacheSystem Organ Class: 10029205 - Nervous system disordersEUCTR2015-005234-21-BEEli Lilly and Company324
Active, not recruiting
Phase 1
A Study in Patients With Cluster HeadacheEpisodic Cluster Headache, Chronic Cluster HeadacheMedDRA version: 20.0Level: PTClassification code 10059133Term: Cluster headacheSystem Organ Class: 10029205 - Nervous system disordersEUCTR2015-005234-21-FIEli Lilly and Company324